Phase I Study of Tumor Treating Fields (TTF) in Combination With Cabozantinib or With Pembrolizumab and Nab-Paclitaxel in Patients With Advanced Solid Tumors Involving the Abdomen or Thorax
M.D. Anderson Cancer Center
M.D. Anderson Cancer Center
Actuate Therapeutics Inc.
OHSU Knight Cancer Institute
OHSU Knight Cancer Institute
Infinity Pharmaceuticals, Inc.
University of California, San Francisco